IntelGenx Technologies Corp. IntelGenx Technologies Corp.

IntelGenx Technologies Corp.

IGX

주식 순위 #28065
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
주가
$0.17446996
마지막 동기화: 2024-06-11
시가총액
$26.97M
변동 (1일)
-0.57%
변동 (1년)
2.63%
국가
CA
거래 IntelGenx Technologies Corp. (IGX)

카테고리

Healthcare
IntelGenx Technologies Corp. (IGX)의 주가 이력
최고 종가: $0.17 (2025-05-01 기준)

최저 종가: $0.71 (2007-01-01 기준)
IntelGenx Technologies Corp.의 주가 이력 (2007 ~ 2026)
연간 주가 성과
연도 성과
2025 0.00%
2024 25.41%
2023 -7.05%
2022 -63.89%
2021 65.40%
2020 -50.36%
2019 -8.97%
2018 -25.87%
2017 -2.69%
2016 47.56%
2015 -7.76%
2014 6.34%
2013 -14.80%
2012 26.81%
2011 48.44%
2010 -44.05%
2009 73.36%
2008 -50.74%
2007 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$520.06 22.00%
US
$249.65 808.13%
US
$138.33 -3.31%
AU
$887.09 6.27%
NL
$752.87 7.40%
CH